Warfarin is one member of the anticoagulant class that presents a challenge to clinicians. Low-molecular weight heparins can be equally tricky, especially when it comes to dosing decisions in the obese, the renally compromised, and in patients with evolving pharmacokinetic profiles. How can we tailor our clinical approach to specific subtypes of patients who require anticoagulant therapy? Dr. Kate Phillips, clinical specialist in cardiology and anticoagulation at the Boston Medical Center, details special considerations for our approach to care. Dr. Charles Turck hosts.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Factoring Specific Patient Profiles Into Anticoagulation Care
Restart
Resume
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Recommended
Details
Presenters
Comments
Recommended
Overview
Warfarin is one member of the anticoagulant class that presents a challenge to clinicians. Low-molecular weight heparins can be equally tricky, especially when it comes to dosing decisions in the obese, the renally compromised, and in patients with evolving pharmacokinetic profiles. How can we tailor our clinical approach to specific subtypes of patients who require anticoagulant therapy? Dr. Kate Phillips, clinical specialist in cardiology and anticoagulation at the Boston Medical Center, details special considerations for our approach to care. Dr. Charles Turck hosts.
Facebook Comments